Pharmacokinetics and toxicity of an yttrium‐90‐citc‐dtpa‐hmfg1 radioimmunoconjugate for intraperitoneal radioimmunotherapy of ovarian cancer

Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin.

1987 • 484 citations

Peripheral Neuropathy

1985 • 276 citations

Radionuclide selection and model absorbed dose calculations for radiolabeled tumor associated antibodies

1984 • 259 citations

Antibodies against metal chelates

1985 • 253 citations

Cancer Statistics, 1987

1987 • 241 citations

Antibody-guided irradiation of advanced ovarian cancer with intraperitoneally administered radiolabeled monoclonal antibodies.

1987 • 205 citations

Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody

1993 • 171 citations

Specific IgE antibodies to platinum salts in sensitized workers

1979 • 168 citations

The peptide way to macrocyclic bifunctional chelating agents: synthesis of 2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecane-N,N',N",N'''-tetraacetic acid and study of its yttrium(III) complex

1988 • 167 citations

Phase I-II studies of yttrium-labeled antiferritin treatment for end-stage Hodgkin's disease, including Radiation Therapy Oncology Group 87-01.

1991 • 123 citations

Intraperitoneal yttrium-90-labeled monoclonal antibody in ovarian cancer.

1990 • 122 citations

Pharmacokinetics and immune response of 131I-chimeric mouse/human B72.3 (human gamma 4) monoclonal antibody in humans.

1991 • 118 citations

A study of in vivo immune complex formation and clearance in man.

1990 • 118 citations

A comparative study of the cytotoxicity and DNA-damaging effects of cis-(diammino)(1,1-cyclobutanedicarboxylato)-platinum(II) and cis-diamminedichloroplatinum(II) on L1210 cells.

1985 • 106 citations

The curability of tumours of differing size by targeted radiotherapy using 131I or 90Y

1991 • 105 citations

Antibodies elicited against cis-diamminedichloroplatinum(II)-modified DNA are specific for cis-diamminedichloroplatinum(II)-DNA adducts formed in vivo and in vitro.

1982 • 98 citations

Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy.

1992 • 86 citations

Monoclonal antibodies : applications in clinical oncology

1991 • 69 citations

Intraperitoneal immunotherapy of human ovarian carcinoma with Corynebacterium parvum.

1983 • 69 citations

Radiocolloids in the Treatment of Ovarian Cancer

1979 • 63 citations

Intraperitoneal recombinant alpha-2-interferon alternating with cisplatin as salvage therapy for minimal residual-disease ovarian cancer: a phase II study.

1990 • 61 citations

Selection of reagents for human radioimmunotherapy

1992 • 34 citations

Intraperitoneal cisplatin-based chemotherapy for ovarian carcinoma.

1991 • 24 citations

Intratumoral and whole-body distributions of C110 anti-carcinoembryonic antigen radioimmunotoxin after intraperitoneal and intravenous injection: a quantitative autoradiographic study.

1992 • 19 citations

Induction of immunogenicity of monoclonal antibodies by conjugation with drugs.

1991 • 16 citations